Literature DB >> 28507397

Managing the drug treatment of rheumatoid arthritis.

Tom D Wilsdon1, Catherine L Hill2.   

Abstract

Entities:  

Keywords:  disease-modifying antirheumatic drugs (DMARDs); immunosuppression; rheumatoid arthritis

Year:  2017        PMID： 28507397      PMCID： PMC5408004          DOI： 10.18773/austprescr.2017.012

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  29 in total

1.  Patterns of cardiovascular risk in rheumatoid arthritis.

Authors:  D H Solomon; N J Goodson; J N Katz; M E Weinblatt; J Avorn; S Setoguchi; C Canning; S Schneeweiss
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

2.  The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study.

Authors:  Marita Cross; Emma Smith; Damian Hoy; Loreto Carmona; Frederick Wolfe; Theo Vos; Benjamin Williams; Sherine Gabriel; Marissa Lassere; Nicole Johns; Rachelle Buchbinder; Anthony Woolf; Lyn March
Journal:  Ann Rheum Dis       Date:  2014-02-18       Impact factor: 19.103

Review 3.  Herbal therapy for treating rheumatoid arthritis.

Authors:  Melainie Cameron; Joel J Gagnier; Sigrun Chrubasik
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

Review 4.  Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?

Authors:  Andrew McLean-Tooke; Catherine Aldridge; Sheila Waugh; Gavin P Spickett; Lesley Kay
Journal:  Rheumatology (Oxford)       Date:  2009-05-15       Impact factor: 7.580

Review 5.  The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.

Authors:  Sarah L Westlake; Alexandra N Colebatch; Janis Baird; Patrick Kiely; Mark Quinn; Ernest Choy; Andrew J K Ostor; Christopher J Edwards
Journal:  Rheumatology (Oxford)       Date:  2009-11-27       Impact factor: 7.580

Review 6.  Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis.

Authors:  Manjari Lahiri; William G Dixon
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-06-12       Impact factor: 4.098

Review 7.  Methotrexate for treating rheumatoid arthritis.

Authors:  Maria Angeles Lopez-Olivo; Harish R Siddhanamatha; Beverley Shea; Peter Tugwell; George A Wells; Maria E Suarez-Almazor
Journal:  Cochrane Database Syst Rev       Date:  2014-06-10

8.  Management of pregnancy in women with rheumatoid arthritis.

Authors:  Gene-Siew Ngian; Andrew M Briggs; Ilana N Ackerman; Sharon Van Doornum
Journal:  Med J Aust       Date:  2016-02-01       Impact factor: 7.738

Review 9.  Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis.

Authors:  Irene S Kourbeti; Panayiotis D Ziakas; Eleftherios Mylonakis
Journal:  Clin Infect Dis       Date:  2014-03-18       Impact factor: 9.079

Review 10.  Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

Authors:  Beverley Shea; Michael V Swinden; Elizabeth Tanjong Ghogomu; Zulma Ortiz; Wanruchada Katchamart; Tamara Rader; Claire Bombardier; George A Wells; Peter Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31
View more
  14 in total

Review 1.  Prescribing for polymyalgia rheumatica.

Authors:  David F Liew; Claire E Owen; Russell R Buchanan
Journal:  Aust Prescr       Date:  2018-02-01

2.  Determinants of first-line biological treatment in patients with rheumatoid arthritis: Results from an observational study.

Authors:  Laura Angelici; Antonio Addis; Nera Agabiti; Ursula Kirchmayer; Marina Davoli; Valeria Belleudi
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

3.  Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis.

Authors:  Dan Zhang; Jin-Tao Lyu; Bing Zhang; Xiao-Meng Zhang; Hao Jiang; Zhi-Jian Lin
Journal:  BMC Complement Med Ther       Date:  2020-07-06

Review 4.  'RA and the microbiome: do host genetic factors provide the link?

Authors:  Philippa M Wells; Frances M K Williams; M L Matey-Hernandez; Cristina Menni; Claire J Steves
Journal:  J Autoimmun       Date:  2019-03-05       Impact factor: 7.094

5.  Double-layered osmotic pump controlled release tablets of actarit: In vitro and in vivo evaluation.

Authors:  Yuenan Li; Hao Pan; Hongliang Duan; Jianting Chen; Zhihong Zhu; Jingxin Fan; Pingfei Li; Xinggang Yang; Weisan Pan
Journal:  Asian J Pharm Sci       Date:  2018-08-19       Impact factor: 6.598

6.  Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China.

Authors:  Nan Jiang; Pingting Yang; Shengyun Liu; Hongbin Li; Lijun Wu; Xiaofei Shi; Yongfei Fang; Yi Zhao; Jian Xu; Zhenyu Jiang; Zhenbiao Wu; Xinwang Duan; Qian Wang; Xinping Tian; Mengtao Li; Xiaofeng Zeng
Journal:  Patient Prefer Adherence       Date:  2020-06-23       Impact factor: 2.711

7.  Baicalin alleviates collagen‑induced arthritis and suppresses TLR2/MYD88/NF‑κB p65 signaling in rats and HFLS‑RAs.

Authors:  Lin Bai; Ya Bai; Yuxin Yang; Wei Zhang; Ling Huang; Rui Ma; Li Wang; Haizheng Duan; Qiaofeng Wan
Journal:  Mol Med Rep       Date:  2020-07-28       Impact factor: 2.952

8.  BT2 Suppresses Human Monocytic-Endothelial Cell Adhesion, Bone Erosion and Inflammation.

Authors:  Mei-Chun Yeh; Ben J Wu; Yue Li; Mina Elahy; Leonel Prado-Lourenco; Jim Sockler; Herman Lau; Ric O Day; Levon M Khachigian
Journal:  J Inflamm Res       Date:  2021-03-23

9.  International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patients.

Authors:  Zahra Rezaieyazdi; Abid Farooqi; Hossein Soleymani-Salehabadi; Arman Ahmadzadeh; Mona Aslani; Saiedeh Omidian; Arezoo Sadoughi; Zohreh Vahidi; Mandana Khodashahi; Shazia Zamurrad; Seyed Shahabeddin Mortazavi-Jahromi; Hossein Fallahzadeh; Mostafa Hosseini; Zahra Aghazadeh; Parvin Ekhtiari; Hidenori Matsuo; Bernd H A Rehm; Salvatore Cuzzocrea; Antimo D'Aniello; Abbas Mirshafiey
Journal:  Inflammopharmacology       Date:  2019-01-02       Impact factor: 5.093

10.  The Sufficient Immunoregulatory Effect of Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation on Regulatory T Cells in Patients with Refractory Rheumatoid Arthritis.

Authors:  Mohsen Ghoryani; Zhaleh Shariati-Sarabi; Jalil Tavakkol-Afshari; Mojgan Mohammadi
Journal:  J Immunol Res       Date:  2020-04-28       Impact factor: 4.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.